Search Results

Tumor hypoxia is characterized by extremely low levels of oxygen (<15.2 mmHg/2% O2). It occurs in fifty percent1 of all tumors and is a well-established negative prognostic indicator. Poor outcomes are seen in patients with hypoxic tumors in cancers including breast, cervical, head and neck, soft... More

Asimov's technology is a synthetic biology CAD platform (Cello) that we developed at MIT to program living cells with "genetic circuits". We have used it to design the most complex sense-and-response cell behaviors to date. We are now extending the platform to build genetic control modules for cell... More

Syzygy Plasmonics is commercializing a radical new technology developed at Rice University. Our technology enables us to turn traditional catalysts into high efficiency photocatalysts. This conversion allows us to produce chemical reactors that are powered by light instead of burning fuel and... More

Cellino has built the first platform that enables precise control over iPS cell fate in their natural environment. Their proprietary delivery technology, NanoLaze, delivers synthetic biology tools to control the sequence of genes being turned on and off inside a cell. This offers precise, “digital”... More

Jeeva is building an edge-to-cloud service platform, deploying high-volume disposable and battery-free streaming wireless sensors that gather real-time intelligence from item-level products directly at point of use and throughout distribution.